0001127602-24-009000.txt : 20240307 0001127602-24-009000.hdr.sgml : 20240307 20240307160516 ACCESSION NUMBER: 0001127602-24-009000 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240305 FILED AS OF DATE: 20240307 DATE AS OF CHANGE: 20240307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Desjarlais John R CENTRAL INDEX KEY: 0001591313 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36182 FILM NUMBER: 24730028 MAIL ADDRESS: STREET 1: C/O XENCOR, INC. STREET 2: 111 WEST LEMON AVENUE CITY: MONROVIA STATE: CA ZIP: 91016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xencor Inc CENTRAL INDEX KEY: 0001326732 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 201622502 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 465 N. HALSTEAD ST. STREET 2: SUITE 200 CITY: PASADENA STATE: CA ZIP: 91107 BUSINESS PHONE: 626-305-5900 MAIL ADDRESS: STREET 1: 465 N. HALSTEAD ST. STREET 2: SUITE 200 CITY: PASADENA STATE: CA ZIP: 91107 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-03-05 0001326732 Xencor Inc XNCR 0001591313 Desjarlais John R C/O XENCOR, INC. 465 N HALSTEAD STREET, SUITE 200 PASADENA CA 91107 1 SR. VICE PRESIDENT & CSO 0 Common Stock 2024-03-05 4 S 0 6629 23.429 D 166989 D Common Stock 2024-03-05 4 A 0 20724 0 A 187713 D Stock Options 22.85 2024-03-05 4 A 0 124346 0 A 2034-03-04 Common Stock 124346 124346 D Represents the disposition of shares that were sold to pay withholding taxes upon vesting of 18,195 restricted stock units. Represents restricted stock units that vest as follows: 1/3 of the shares vest on the first, second and third anniversaries of the date of grant. 25% of the shares subject to the option shall vest on the one year anniversary of March 5, 2024 (the "Vesting Commencement Date") and 1/48th of the shares shall vest monthly thereafter, such that the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. /s/ Celia E. Eckert, Attorney-in-Fact 2024-03-06